Stay updated on JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial
Sign up to get notified when there's something new on the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page.

Latest updates to the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page
- Check4 days agoChange DetectedThe record history now shows a new site release, version 3.6.3, replacing the previous 3.6.2 entry.SummaryDifference0.1%

- Check11 days agoChange DetectedA new revision entry v3.6.2 was added to the study's record history and the previous v3.6.0 entry was removed, updating the revision log for the record. This is an administrative version control change that does not modify study data or public content.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe record history now shows that recruitment is closed with a 'No longer looking for participants' entry, indicating the study is not enrolling. This update is paired with a new version note (v3.6.0) and the removal of the older revision label (v3.5.5) to reflect changes in the study’s version history.SummaryDifference0.4%

- Check32 days agoChange DetectedThe study record history now shows a new revision labeled v3.5.5, indicating an update to the record. The prior revision v3.5.4 is superseded as the latest entry.SummaryDifference0.1%

- Check54 days agoChange DetectedThe history now shows Revision: v3.5.4, replacing v3.5.3. This indicates a new build/version for the page, with no visible changes to the study record content.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision tag on the page shows v3.5.3, replacing the previous v3.5.2. This reflects an updated build of the page’s history metadata rather than a change to study data or visible content.SummaryDifference0.1%

Stay in the know with updates to JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JS002 Multiple-dose Safety and Efficacy in Hyperlipidemia Clinical Trial page.